What to expect from drug discovery and development in 2023
Drug Discovery World
JANUARY 26, 2023
According to research from Deloitte 1 , the average ROI in R&D for global pharma companies fell to just 1.2% The modernisation of R&D models could be key to reducing spend on new drugs, a point that Deloitte makes about the need to transform the clinical trials process. the industry experienced in 2021.
98 
Let's personalize your content